LJPC logo

La Jolla Pharmaceutical (LJPC) Total Assets

Annual Total Assets

$101.23 M
+$28.99 M+40.12%

December 31, 2021

Summary

Performance

1-Year Change

+40.12%

3-Year Change

-50.45%

5-Year Change

-15.32%

15-Year Change

-15.32%

LJPC Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$204.29 M
LJPC annual total assets is currently -50.45% below its historical high of $204.29 million

3-Year Low

$101.23 M
LJPC annual total assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
LJPC previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
LJPC next annual earnings announcement has not yet been scheduled

OtherLJPCbalance sheetmetrics:

Annual Current Assets

$67.31 M
LJPC annual total current assets is $67.31 million

Annual Non Current Assets

$33.91 M
LJPC annual long term assets is $33.91 million

Annual Total Liabilities

$167.97 M
LJPC annual total liabilities is $167.97 million

Annual Current Liabilities

$17.64 M
LJPC annual total current liabilities is $17.64 million

Quarterly Total Assets

$99.37 M
+$2.99 M+3.10%

June 30, 2022

Summary

Performance

3-Month Change

+3.1%

1-Year Change

-0.64%

3-Year Change

-41.51%

5-Year Change

-33.13%

LJPC Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$273.14 M
LJPC quarterly total assets is currently -63.62% below its historical high of $273.14 million

3-Year Low

$96.38 M
LJPC quarterly total assets is currently +3.10% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
LJPC previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
LJPC next earnings announcement has not yet been scheduled

OtherLJPCbalance sheetmetrics:

Quarterly Current Assets

$66.36 M
LJPC quarterly total current assets is $66.36 million

Quarterly Non Current Assets

$33.01 M
LJPC quarterly long term assets is $33.01 million

Quarterly Total Liabilities

$168.83 M
LJPC quarterly total liabilities is $168.83 million

Quarterly Current Liabilities

$16.49 M
LJPC quarterly total current liabilities is $16.49 million

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

Annual Total Assets

$101.23 M
LJPC annual total assets is $101.23 million

Annual Non Current Assets

$33.91 M
LJPC annual long term assets is $33.91 million

Annual Current Assets

$67.31 M
LJPC annual total current assets is $67.31 million

LJPC Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+40.1%-0.6%
3 y3 years-50.5%-41.5%
5 y5 years-15.3%-33.1%

LJPC Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-1.8%-3.0%
5 y5-year-23.5%-28.6%-24.9%-27.3%
alltimeall time-50.4%-96.6%-63.6%-98.0%

La Jolla Pharmaceutical Total Assets History

DateAnnualQuarterly
Jun 2022
-
$99.37 M(+3.1%)
Mar 2022
-
$96.38 M(-4.8%)
Dec 2021
$101.23 M(+40.1%)
$101.23 M(+0.9%)
Sep 2021
-
$100.29 M(+0.3%)
Jun 2021
-
$100.01 M(+11.6%)
Mar 2021
-
$89.59 M(+24.0%)
Dec 2020
$72.24 M(-45.4%)
$72.24 M(-10.5%)
Sep 2020
-
$80.72 M(-24.8%)
Jun 2020
-
$107.39 M(-9.1%)
Mar 2020
-
$118.21 M(-10.6%)
Dec 2019
$132.25 M(-35.3%)
$132.25 M(-11.3%)
Sep 2019
-
$149.14 M(-12.2%)
Jun 2019
-
$169.89 M(-9.5%)
Mar 2019
-
$187.83 M(-8.1%)
Dec 2018
$204.29 M(+70.9%)
$204.29 M(-13.8%)
Sep 2018
-
$237.07 M(-13.2%)
Jun 2018
-
$273.14 M(+46.1%)
Mar 2018
-
$186.90 M(+56.4%)
Dec 2017
$119.54 M(+68.9%)
$119.54 M(-8.1%)
Sep 2017
-
$130.06 M(-12.5%)
Jun 2017
-
$148.59 M(-11.6%)
Mar 2017
-
$168.01 M(+137.3%)
Dec 2016
$70.80 M(-45.3%)
$70.80 M(-20.9%)
Sep 2016
-
$89.52 M(-14.6%)
Jun 2016
-
$104.77 M(-10.5%)
Mar 2016
-
$117.01 M(-9.5%)
Dec 2015
$129.35 M(+156.0%)
$129.35 M(-6.2%)
Sep 2015
-
$137.94 M(+256.2%)
Jun 2015
-
$38.73 M(-14.9%)
Mar 2015
-
$45.54 M(-9.9%)
Dec 2014
$50.54 M(+477.8%)
$50.54 M(-7.2%)
Sep 2014
-
$54.44 M(+1207.9%)
Jun 2014
-
$4.16 M(-32.1%)
Mar 2014
-
$6.13 M(-29.9%)
Dec 2013
$8.75 M(+155.0%)
$8.75 M(-19.2%)
Sep 2013
-
$10.82 M(+445.7%)
Jun 2013
-
$1.98 M(-29.5%)
Mar 2013
-
$2.81 M(-18.0%)
Dec 2012
$3.43 M(-32.7%)
$3.43 M(+0.8%)
Sep 2012
-
$3.40 M(-12.8%)
Jun 2012
-
$3.90 M(-11.9%)
Mar 2012
-
$4.43 M(-13.1%)
Dec 2011
$5.10 M(-26.4%)
$5.10 M(-7.5%)
Sep 2011
-
$5.51 M(-5.2%)
Jun 2011
-
$5.81 M(-13.9%)
Mar 2011
-
$6.75 M(-2.7%)
Dec 2010
$6.93 M(+43.2%)
$6.93 M(-6.8%)
Sep 2010
-
$7.43 M(-9.6%)
Jun 2010
-
$8.22 M(+121.7%)
Mar 2010
-
$3.71 M(-23.4%)
Dec 2009
$4.84 M(-76.8%)
$4.84 M(-26.4%)
Sep 2009
-
$6.58 M(-32.7%)
Jun 2009
-
$9.77 M(-50.3%)
Mar 2009
-
$19.68 M(-5.6%)
Dec 2008
$20.84 M
$20.84 M(-32.2%)
Sep 2008
-
$30.75 M(-33.5%)
Jun 2008
-
$46.21 M(+53.1%)
DateAnnualQuarterly
Mar 2008
-
$30.18 M(-32.0%)
Dec 2007
$44.41 M(-10.3%)
$44.41 M(-19.8%)
Sep 2007
-
$55.36 M(-16.8%)
Jun 2007
-
$66.54 M(+70.2%)
Mar 2007
-
$39.09 M(-21.1%)
Dec 2006
$49.52 M(-38.8%)
$49.52 M(-13.7%)
Sep 2006
-
$57.38 M(-12.5%)
Jun 2006
-
$65.57 M(-11.0%)
Mar 2006
-
$73.65 M(-9.0%)
Dec 2005
$80.93 M(+145.0%)
$80.93 M(+235.9%)
Sep 2005
-
$24.09 M(-22.2%)
Jun 2005
-
$30.96 M(-21.5%)
Mar 2005
-
$39.45 M(+19.5%)
Dec 2004
$33.03 M(-21.3%)
$33.03 M(-27.3%)
Sep 2004
-
$45.40 M(-17.0%)
Jun 2004
-
$54.69 M(-14.2%)
Mar 2004
-
$63.73 M(+52.0%)
Dec 2003
$41.94 M(-32.2%)
$41.94 M(-15.5%)
Sep 2003
-
$49.67 M(+36.0%)
Jun 2003
-
$36.52 M(-25.6%)
Mar 2003
-
$49.10 M(-20.6%)
Dec 2002
$61.86 M(+19.7%)
$61.86 M(-16.0%)
Sep 2002
-
$73.62 M(-9.7%)
Jun 2002
-
$81.55 M(-11.1%)
Mar 2002
-
$91.73 M(+77.5%)
Dec 2001
$51.69 M(+20.2%)
$51.69 M(-11.0%)
Sep 2001
-
$58.07 M(-8.3%)
Jun 2001
-
$63.32 M(-11.9%)
Mar 2001
-
$71.88 M(+67.1%)
Dec 2000
$43.02 M(+206.3%)
$43.02 M(-6.2%)
Sep 2000
-
$45.87 M(+115.8%)
Jun 2000
-
$21.26 M(-12.5%)
Mar 2000
-
$24.29 M(+73.0%)
Dec 1999
$14.04 M(-45.6%)
$14.04 M(-15.9%)
Sep 1999
-
$16.70 M(-18.5%)
Jun 1999
-
$20.50 M(-13.9%)
Mar 1999
-
$23.80 M(-7.8%)
Dec 1998
$25.80 M(-12.8%)
$25.80 M(+10.7%)
Sep 1998
-
$23.30 M(-6.8%)
Jun 1998
-
$25.00 M(-8.8%)
Mar 1998
-
$27.40 M(-7.4%)
Dec 1997
$29.60 M(-6.6%)
$29.60 M(-5.7%)
Sep 1997
-
$31.40 M(+7.2%)
Jun 1997
-
$29.30 M(-5.5%)
Mar 1997
-
$31.00 M(-2.2%)
Dec 1996
$31.70 M(+20.1%)
$31.70 M(+18.3%)
Sep 1996
-
$26.80 M(+31.4%)
Jun 1996
-
$20.40 M(-11.7%)
Mar 1996
-
$23.10 M(-12.5%)
Dec 1995
$26.40 M(+54.4%)
$26.40 M(+22.8%)
Sep 1995
-
$21.50 M(0.0%)
Jun 1995
-
$21.50 M(+49.3%)
Mar 1995
-
$14.40 M(-15.8%)
Dec 1994
$17.10 M
$17.10 M(-11.4%)
Sep 1994
-
$19.30 M(-11.9%)
Jun 1994
-
$21.90 M(+217.4%)
Mar 1994
-
$6.90 M

FAQ

  • What is La Jolla Pharmaceutical annual total assets?
  • What is the all time high annual total assets for La Jolla Pharmaceutical?
  • What is La Jolla Pharmaceutical annual total assets year-on-year change?
  • What is La Jolla Pharmaceutical quarterly total assets?
  • What is the all time high quarterly total assets for La Jolla Pharmaceutical?
  • What is La Jolla Pharmaceutical quarterly total assets year-on-year change?

What is La Jolla Pharmaceutical annual total assets?

The current annual total assets of LJPC is $101.23 M

What is the all time high annual total assets for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high annual total assets is $204.29 M

What is La Jolla Pharmaceutical annual total assets year-on-year change?

Over the past year, LJPC annual total assets has changed by +$28.99 M (+40.12%)

What is La Jolla Pharmaceutical quarterly total assets?

The current quarterly total assets of LJPC is $99.37 M

What is the all time high quarterly total assets for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high quarterly total assets is $273.14 M

What is La Jolla Pharmaceutical quarterly total assets year-on-year change?

Over the past year, LJPC quarterly total assets has changed by -$642.00 K (-0.64%)